Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus ERIC kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Opioid Use among Social Security Disability Insurance Applicants, 2013-2018

Title: Opioid Use among Social Security Disability Insurance Applicants, 2013-2018
Language: English
Authors: Nicole Maestas (ORCID 0000-0001-5819-0108); Tisamarie B. Sherry; Alexander Strand
Source: Journal of Disability Policy Studies. 2024 35(1):43-53.
Availability: SAGE Publications and Hammill Institute on Disabilities. 2455 Teller Road, Thousand Oaks, CA 91320. Tel: 800-818-7243; Tel: 805-499-9774; Fax: 800-583-2665; e-mail: journals@sagepub.com; Web site: https://sagepub.com
Peer Reviewed: Y
Page Count: 11
Publication Date: 2024
Sponsoring Agency: Social Security Administration (SSA); National Institute on Aging (NIA) (DHHS/NIH)
Contract Number: DRC1200000205; RDR18000003
Document Type: Journal Articles; Reports - Research
Descriptors: Drug Use; Narcotics; Welfare Services; Insurance; Incidence; Natural Language Processing; Algorithms; Data Analysis; Trend Analysis
DOI: 10.1177/10442073221150613
ISSN: 1044-2073; 1538-4802
Abstract: Opioid use is common among Social Security Disability Insurance (SSDI) beneficiaries, who account for a disproportionate share of opioid-related hospitalizations and mortality in the United States. However, little is known about the prevalence of opioid use prior to SSDI enrollment. Understanding when opioid use is established and how it correlates with individual characteristics and community prescribing practices would inform policy approaches to reducing opioid-related harm among SSDI beneficiaries. We estimated the prevalence of opioid use among SSDI applicants by applying a natural language processing algorithm to SSDI application data. We found the prevalence of opioid use among SSDI applicants declined from 33% in 2013 to 24% in 2018. In contrast, the share of applicants with musculoskeletal impairments, which are commonly associated with pain, was unchanged. The share of applications reporting opioid use declined across both sexes, all age groups and education levels, and all regions. There was substantial variation, however, in the magnitude of decline by geography, with the smallest declines in parts of the Midwest and Southeastern United States. SSDI application rates and applications reporting opioid use were more likely to come from communities with higher opioid prescribing rates. Our estimates suggest most SSDI beneficiaries began opioid use prior to entering the SSDI program.
Abstractor: As Provided
Entry Date: 2025
Accession Number: EJ1465847
Database: ERIC